| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 511 | 4.473 | 4.886 | 2.117 | 11.614 | 12.823 | 12.190 | 14.849 |
| Total Income - EUR | - | 0 | 511 | 4.473 | 4.886 | 2.117 | 11.614 | 12.823 | 12.190 | 14.849 |
| Total Expenses - EUR | - | 0 | 5 | 1.400 | 1.355 | 1.022 | 6.638 | 9.182 | 9.811 | 10.093 |
| Gross Profit/Loss - EUR | - | 0 | 506 | 3.073 | 3.531 | 1.095 | 4.976 | 3.641 | 2.379 | 4.756 |
| Net Profit/Loss - EUR | - | 0 | 491 | 2.939 | 3.385 | 1.037 | 4.860 | 3.513 | 2.261 | 4.314 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alergoimuno Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 45 | 551 | 3.043 | 3.476 | 3.228 | 5.479 | 4.125 | 3.439 | 5.402 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 308 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 1.639 | 91 | 53 | 1.065 | 1.917 | 545 | 2.728 |
| Cash | - | 45 | 551 | 1.404 | 3.385 | 3.175 | 4.106 | 2.207 | 2.894 | 2.675 |
| Shareholders Funds | - | 45 | 534 | 2.991 | 3.435 | 3.212 | 4.908 | 3.562 | 2.718 | 4.362 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 16 | 52 | 41 | 16 | 571 | 563 | 721 | 1.041 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergoimuno Diagnostic Srl